[ad_1]
SM entertainment
The singer BoA was investigated by the prosecution for smuggling psychotropic drugs.
On the 17th, SBS ‘8 News’ reported that BoA is under suspicion of secretly bringing multiple psychotropic drugs like zolpidem into Korea from abroad.
BoA was reportedly caught during the customs inspection stage while attempting to bring psychotropic drugs such as zolpidem from Japan through an employee of SM Entertainment’s overseas branch to bring them to Korea. Consequently, BoA and the employee were investigated by the prosecution on the 16th for violating the regulations on imported drugs.
Shortly after the report was released, SM, the agency of the agency, said: “Recalling that the prescription drug for sleep disorders during activities in Japan had no side effects, an employee of our overseas branch was confirmed at a local hospital and received the drug through a normal procedure, but drugs that were normally prescribed abroad. “I didn’t even realize it could be a problem in Korea.”
The following is the full text of SM Entertainment’s official position.
We would like to express our position on the content related to the artist BoA reported today.
This incident was caused by the mistake of an employee of our overseas branch who had no knowledge of trade and customs clearance. First of all, I would like to express my sincere apology for causing concern not only to fans but also to many people.
It is true that an employee of a branch abroad delivered the medicine by mail without formal import customs clearance procedures, but it was a mistake due to ignorance, not in trying to bring it in illegally. In this regard, I would like to give you a detailed explanation.
As a result of a recent medical exam, BoA received a doctor’s opinion that she needed enough sleep due to a decrease in growth hormone, so she took a prescribed sleeping pill on the doctor’s recommendation. However, side effects such as dizziness and digestive problems such as vomiting were severely observed, and we spoke with the staff about this unfavorable situation.
As a result, the employees who had lived together in Japan were concerned about BoA’s health. I remembered that, and due to COVID-19, I was able to pick up a representative, so I got confirmation from the local hospital and followed the normal procedure to pick up the medication.
The clerk has been confirmed at the local post office that it is possible to send medicine from Japan to Korea by attaching documents such as the ingredient list, but not realizing that even drugs normally prescribed abroad can be problematic in Korea. I am shipping medicine to Korea with the attachment.
Since we were not aware of customs and trade clearance practices and procedures, we were completely unaware that we had to obtain permission from a government agency to handle and import pharmaceuticals, and that even those who were licensed had to obtain prior notice and permission to import. . Without even knowing the problem, they made a mistake sending the drug to the local post office only when they were informed that the drug could be shipped overseas if an ingredient label was attached.
The employee, who became aware of his mistake after recently being contacted by an investigative agency, actively cooperated with the investigative agency to investigate this matter and promised not to make that mistake again.
Also, in the course of the investigation, we first said that it is a drug that is delivered to BoA, and we sincerely clarified the facts and supporting data.
To prevent this from happening again, we plan to strengthen training in all areas of our employees. We seem to regret the inconvenience this has caused many people.
Once again, we sincerely apologize for causing concern.
Meanwhile, the prosecution plans to decide whether to prosecute the prosecution by exhaustively judging whether the BoA was actually administered and whether there was intent to smuggle it.
Kim Im-soo Editor: [email protected]
[ad_2]
